{"name":"Valen Labs","slug":"valen-labs","ticker":"","exchange":"","domain":"","description":"Valen Labs is a biotechnology company focused on the development of innovative treatments, with a primary focus on D-Ribose under the brand CORvalen. Despite having a single drug in its pipeline, the company has made significant strides in researching and developing this compound, though it is currently discontinued.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPa2RXbk5GYVJFM2FYQjktWHlfdlc5aDIwbmxBa2JEYUFkNkNrT1NuZDIyT2R5MTVkRXdrbk1UcTBpUlpRNTdjZWJ3TzF0d0k0ckRkXzVwZEpneVZKMWU1bGVXVGVBVU4wOEswZVlJNlhyMlhJVksyc29PRHdPaGw0WDBpMlJQdlA4R0NCbktRaTdSQlVBa0lRR3h2US1RX2RGTklsLWxIUTROTWRyU1E?oc=5","date":"2024-11-26","type":"pipeline","source":"C&EN","summary":"Aizen Therapeutics launches to develop mirror peptides - C&EN","headline":"Aizen Therapeutics launches to develop mirror peptides - C&EN","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}